Various 2-(4'-methyl-N-phenyl substituted)-1,1'-biphenyl-2-ylcarboxamido-2-oxoethyl nitrate analogues were synthesized and evaluated for analgesic, anti-inflammatory, ulcerogenic activity and nitric oxide release study. Compounds VM-4, VM-6, VM-9, VM-10, VM-11 and VM-12 exhibited good analgesic and anti-inflammatory activity compared to standard drug diclofenac. The compounds also showed decreased gastro-intestinal ulcerogenicity and gastro-protective activity in histopathological studies resulting in absence of mucosal injury. All the synthesized compounds were found to have significant in vivo nitric oxide releasing activity. The molecular docking was performed to understand the binding mode of these compounds. Results of this study indicated that these NO-NSAIDs may have affinity towards COX-2 active site which can further be explored for selective or non-selective inhibitors.
Shinde MG, Modi SJ, Kulkarni VM. Synthesis, Pharmacological Evaluation, Molecular Docking and in silico ADMET Prediction of Nitric Oxide Releasing Biphenyls as Anti-Inflammatory Agents. J App Pharm Sci, 2017; 7 (10): 037-047.
Year
Month
Molecular Docking and Simulation studies of Farnesyl Trasnferase with the potential inhibitor Theflavin
R. Balajee, M. S. Dhana RajanDeciphering the Binding of Natural Terpenoids to Mycobacterium tuberculosis Type III Polyketide Synthase18 (PKS18): An In-Silico Approach
Synthesis of novel Naphthalene COX inhibitors for anti-inflammatory activity